Tiziana Life Sciences Ltd.
55 Park Lane
London
W1k 1NA
| March 1, 2022 |
VIA EDGAR
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Alan Campbell
| Re: | Tiziana Life Sciences Ltd. |
| Amendment No. 1 to Form F-3 Registration Statement | |
| Filed February 25, 2022 | |
| File No. 333-252441 |
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Tiziana Life Sciences Ltd. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 4:00 p.m., Eastern Standard Time, on Thursday, March 3, 2022, or as soon thereafter as possible.
Please notify Jeffrey Fessler of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3067 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.
| TIZIANA LIFE SCIENCES LTD. | ||
| By: | /s/ Kunwar Shailubhai | |
| Name: | Kunwar Shailubhai | |
| Title: | Chief Executive Officer | |
